Oligopeptide treatment of NF-κB mediated inflammation
US7175679B2 · kind B2 · utility
15Cited by
18References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 21, 2001 |
| Grant date | Feb 13, 2007 |
| Priority date | — |
| Expiry date | Oct 17, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/59
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the modulation of gene expression in a cell, also called gene control, in particular in relation to the treatment of anthrax. The invention provides a method for modulating expression of a gene in a cell comprising providing the cell with a signaling molecule comprising a peptide or functional analogue thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.